![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Drug-Drug Interactions with Grazoprevir/Elbasvir: Practical Considerations for the Care of HIV/HCV Co-Infected Patients
|
|
|
Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy. Washington DC, May 26-28, 2015
Wendy W Yeh, MD
Merck
![Pharm1.gif](../images/060315/060315-2/Pharm1.gif)
![Pharm2.gif](../images/060315/060315-2/Pharm2.gif)
![Pharm3.gif](../images/060315/060315-2/Pharm3.gif)
![Pharm4.gif](../images/060315/060315-2/Pharm4.gif)
![Pharm5.gif](../images/060315/060315-2/Pharm5.gif)
![Pharm6.gif](../images/060315/060315-2/Pharm6.gif)
![Pharm7.gif](../images/060315/060315-2/Pharm7.gif)
![Pharm8.gif](../images/060315/060315-2/Pharm8.gif)
![Pharm9.gif](../images/060315/060315-2/Pharm9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|